中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
机构
  • 合肥物质科学研究院 [13]
采集方式
内容类型
发表日期
  • 2022 [13]
学科主题
筛选

浏览/检索结果: 共13条，第1-10条 帮助

限定条件                    
条数/页： 排序方式：
Endothelial cell heterogeneity and microglia regulons revealed by a pig cell landscape at single-cell level (vol 13, 3620, 2022) 期刊论文  OAI收割
NATURE COMMUNICATIONS, 2022, 卷号: 13
作者:  Wang, Fei;  Ding, Peiwen;  Liang, Xue;  Ding, Xiangning;  Brandt, Camilla Blunk
  |  收藏  |  浏览/下载：42/0  |  提交时间：2022/12/23
Thermodynamic simulation and structural optimization of the collimator in the drift duct of EAST-NBI 期刊论文  OAI收割
NUCLEAR ENGINEERING AND TECHNOLOGY, 2022, 卷号: 54
作者:  Tang, Ning;  Hu, Chun-dong;  Xie, Yuan-lai;  Wei, Jiang-long;  Cui, Zhi-Wei
  |  收藏  |  浏览/下载：25/0  |  提交时间：2022/12/23
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor 期刊论文  OAI收割
THORACIC CANCER, 2022
作者:  Wang, Wenxian;  Wang, Qian;  Xu, Chunwei;  Li, Ziming;  Song, Zhengbo
  |  收藏  |  浏览/下载：37/0  |  提交时间：2022/12/23
Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial 期刊论文  OAI收割
BRITISH JOURNAL OF CANCER, 2022
作者:  Qin, Shukui;  Li, Jin;  Zhong, Haijun;  Jin, Chuan;  Chen, Lili
  |  收藏  |  浏览/下载：20/0  |  提交时间：2022/12/22
A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer 期刊论文  OAI收割
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 卷号: 14
作者:  Yan, Min;  Yuan, Peng;  Ouyang, Quchang;  Cheng, Ying;  Han, Guohui
  |  收藏  |  浏览/下载：36/0  |  提交时间：2022/12/23
Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China 期刊论文  OAI收割
THORACIC CANCER, 2022
作者:  Xu, Chunwei;  Si, Lu;  Wang, Wenxian;  Li, Ziming;  Song, Zhengbo
  |  收藏  |  浏览/下载：39/0  |  提交时间：2022/12/22
Heterodimensional superlattice with in-plane anomalous Hall effect 期刊论文  OAI收割
NATURE, 2022, 卷号: 609
作者:  Zhou, Jiadong;  Zhang, Wenjie;  Lin, Yung-Chang;  Cao, Jin;  Zhou, Yao
  |  收藏  |  浏览/下载：18/0  |  提交时间：2022/12/23
First-in-human, phase I study of AK109, an anti-VEGFR2 antibody, in patients (pts) with advanced or metastatic solid tumors. 期刊论文  OAI收割
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Xu, Nong;  Zheng, Yulong;  Zhong, Haijun;  Zhao, Fuyou;  Zhou, Huan
  |  收藏  |  浏览/下载：26/0  |  提交时间：2022/12/23
Anlotinib plus radiotherapy-temozolomide for newly diagnosed glioblastoma: A prospective, multicenter phase II study. 期刊论文  OAI收割
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Lai, Shuzhen;  Chen, Yuan Yuan Yuan;  Li, Peijing;  Jiang, Fagui;  Liu, Xiaohui
  |  收藏  |  浏览/下载：24/0  |  提交时间：2022/12/23
Systemic Therapy for Hepatocellular Carcinoma: Chinese Consensus-Based Interdisciplinary Expert Statements 期刊论文  OAI收割
LIVER CANCER, 2022, 卷号: 11
作者:  Sun, Yongkun;  Zhang, Wen;  Bi, Xinyu;  Yang, Zhengqiang;  Tang, Yu
  |  收藏  |  浏览/下载：38/0  |  提交时间：2022/12/23